Skip to content
Clinical Trials – home

Iwona Chlebicka Malwa-Med Iwona Chlebicka

Verified siteinfo

Poland ul. Słonimskiego 25, 50-304 Wroclaw, Poland

  • 2 trials recruiting
  • Systemic lupus erythematosus · Chronic kidney disease · Hypertension
  • Adult patients

About Specializations

Iwona Chlebicka Malwa-Med Iwona Chlebicka in Wroclaw, Poland specialises in clinical trials of conditions such as Systemic lupus erythematosus, Chronic kidney disease, Hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Systemic Lupus Erythematosus Research

The medical center is at the forefront of research in systemic lupus erythematosus (SLE), focusing on innovative therapeutic approaches to manage this complex autoimmune disease. The center's research is dedicated to understanding the pathophysiology of SLE and developing new treatments that can significantly improve patient outcomes.

  • Evaluation of new oral medications
  • Long-term safety and tolerability studies
  • Reduction of disease activity

Through its pioneering work, the center contributes to the advancement of autoimmune disease management, offering hope for improved quality of life for patients with SLE.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Słonimskiego 2550-304 WroclawPoland
Recruiting now
2 trials
Conditions studied
3
Partner status
Verified site

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.